[1] [3] This sterile injectable solution may be intended for use in patients requiring enhanced antioxidant support, detoxification, or adjunctive therapy in specific medical conditions
Additionally, Semaglutide is not recommended for individuals with a history of pancreatitis, as there is a slight risk of pancreatic inflammation associated with GLP-1 receptor agonists
Subcutaneously administered Tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials
has received honoraria or has been a consultant for Angelini, AbbVie, Boehringer Ingelheim, Lundbeck and Otsuka
Multiple clinical studies have demonstrated that semaglutide effectively induces weight loss, establishing it as an effective anti-obesity treatment for individuals with overweight or obesity 6,7